Creative Medical Technology Holdings Inc (CELZ)

[pb_trading]

4/23/2018 Shareholder Update: Creative Medical Technology Holdings, Inc. Continues To Extinguish Debt

PR Newswire

PHOENIX, April 23, 2018 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. (OTCQB-CELZ) announced today that additional debt in the amount of $332,000.00 has been extinguished.

As previously announced Creative Medical Technology Holdings, Inc. took on debt in order to advance our technologies and continue towards our goal of commercialization and cash flow.

"We continue to focus on the business at hand and our portfolio including issued patents for the treatment of erectile dysfunction, degenerative disc disease and our amniotic derived stem cell as well as patents pending in the area of neurological damage due to radiation toxicity and stroke amongst others," said Timothy Warbington, CEO of Creative Medical Technology Holdings, Inc.

As announced on March 26, 2018, we will be exhibiting at the American Urological Association conference in May 2018. We're excited to introduce CaverStemTM to a broad base of the urological community.

For those interested in the CaverStemTM procedure, please refer to our website at caverstem.com. Only physicians trained and approved for the CaverStemTM procedure are identified on our website.

About Creative Medical Technology Holdings

Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company currently trading on the OTCQB under the ticker symbol CELZ. For further information about the company go to www.creativemedicaltechnology.com. For more informati

on on our CaverStemTM procedure please go to www.caverstem.com.
https://www.otcmarkets.com/stock/CELZ/news/Shareholder-Update-Creative-Medical-Technology-Holdings-Inc-Continues-To-Extinguish-Debt?id=189955